Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex
Open Access
- 1 November 2015
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (11) , 7153-7155
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Significant Difference in Drug Susceptibility Distribution between Mycobacterium avium and Mycobacterium intracellulareJournal of Clinical Microbiology, 2014
- COL07-03 : La résistance primaire existe-t-elle dans les infections à mycobactéries non tuberculeuses à croissance lente ?Medecine Et Maladies Infectieuses, 2014
- In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated IsolatesJournal of Clinical Microbiology, 2013
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyEuropean Respiratory Journal, 2013
- Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl SequencingAntimicrobial Agents and Chemotherapy, 2011
- The role of efflux pumps in macrolide resistance in Mycobacterium avium complexInternational Journal of Antimicrobial Agents, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Natural and Acquired Macrolide Resistance in MycobacteriaCurrent Drug Targets - Infectious Disorders, 2002
- Molecular basis of clarithromycin-resistance in Mycobacterium avium–intracellulare complexTubercle and Lung Disease, 2000
- Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice daring treatment with clarithromycinJournal of Antimicrobial Chemotherapy, 1995